Signaling Pathways - S-nitrosoglutathione reductase - CETP - Insulin and Insulin-like Receptors - PC-PLC
清除全部
- B3422 U-731221 CitationTarget: PC-PLCSummary: 磷脂酶C,磷脂酶A2和5-LO(5-脂氧合酶)抑制剂
- B1111 N6022Target: S-nitrosoglutathione reductaseSummary: GSNOR抑制剂
- A8440 GSK1838705ATarget: Insulin and Insulin-like Receptors|ALKSummary: ATP竞争性IGF-IR/IR/ALK抑制剂
- A1302 GSK1904529ATarget: Insulin and Insulin-like ReceptorsSummary: IGF-1R/IR 选择性抑制剂
- A1185 BMS-754807Target: Insulin and Insulin-like ReceptorsSummary: 有效的、选择性的IGF-1R和InsR抑制剂
- A3608 MK 0893Target: Insulin and Insulin-like Receptors|Glucagon ReceptorsSummary: 胰高血糖素受体/ IGF-1R拮抗剂
- A3343 D609Target: PC-PLCSummary: PC-PLC抑制剂
- A4377 Evacetrapib (LY2484595)Target: CETPSummary: 强效的CETP选择性抑制剂
- A4375 Anacetrapib (MK-0859)1 Citation中文名: 安塞曲匹Target: CETPSummary: RhCETP/突变型 CETP(C13S) 抑制剂
- A4302 Rosiglitazone maleate中文名: 马来酸罗格列酮Target: Insulin and Insulin-like ReceptorsSummary: PPARγ激动剂,有效的胰岛素敏化剂